Buy These Mispriced Dividend Icons For Retirement Income

Summary

• Realty Income and Merck offer compelling value with strong fundamentals, attractive valuations, and reliable, growing income streams, making them opportunistic buys for long-term investors.
• Realty Income has a diversified portfolio, steady AFFO growth, and a secure, growing dividend, supported by an A-rated balance sheet and low valuation.
• Merck has strong blockbuster drugs, a robust drug pipeline, strong profitability, and a well-protected dividend.
• Both stocks are undervalued relative to historical norms, providing potential for market-beating total returns through above-average yields and solid long-term growth prospects.